Experiment based genome mining of ribosomal natural products

基于实验的核糖体天然产物基因组挖掘

基本信息

项目摘要

DESCRIPTION (provided by applicant): Ribosomally encoded natural products were once thought to be of limited structural diversity and uncommon amongst microbes. Over the past few years, however, this viewpoint has changed due to the increased discovery rate of RNPs possessing newly described structural motifs previously ascribed to their nonribosomal counterparts. Nearly every sequenced genome, including invertebrates, contains the genetic capacity to biosynthesize ribosomally- encoded, post-translationally modified natural products such as lantibiotics, bacteriocins, microcins, cyanobactins, thiopeptides, and lasso peptides, thereby making this class of underappreciated natural products perhaps the most dominant in all of nature. What is lacking, however, is a systematic approach to harvest this ubiquitous class of natural products and assess their unique biosynthetic capacity. The difficulty associated with characterizing RNPs in a systematic fashion can be attributed to their falling outside the scope of not only most therapeutic screening programs but also metabolomic or proteomic approaches due to their larger size, structural diversity and extraordinary number of post-translational modifications. This proposal outlines the developmental strategies to create a set of tools for harnessing the biosynthetic potential of ribosomally encoded natural products through mass spectrometry based genome mining. The techniques and methodologies created as a result of the proposed work will not only be important for the detection of therapeutic lead compounds, but also for the efficient characterization of ribosomally encoded toxins secreted by pathogenic bacteria such as Staphylococcus aureus, Bacillus cereus and Clostridium difficile as well as defensins produced by higher eukaryotes such as marine snails, primates and humans. PUBLIC HEALTH RELEVANCE: This work outlines an approach that experimentally mines genome sequences for genetically encoded molecules that control biology. Such molecules serve as great lead compounds for therapeutic development.
描述(由申请人提供):核糖体编码的天然产物曾被认为具有有限的结构多样性,并且在微生物中不常见。然而,在过去的几年里,这种观点已经改变,由于发现率增加的RNP拥有新描述的结构基序以前归因于他们的非核糖体对应物。几乎每一个测序的基因组,包括无脊椎动物,都含有生物合成核糖体编码的、后修饰的天然产物的遗传能力,所述天然产物例如羊毛硫抗生素、细菌素、微菌素、蓝藻菌素、硫肽和套索肽,从而使得这类未被重视的天然产物可能是所有自然界中最主要的。然而,缺乏的是一种系统的方法来收获这类无处不在的天然产物,并评估其独特的生物合成能力。与以系统方式表征RNP相关的困难可以归因于它们不仅落在大多数治疗筛选程序的范围之外,而且由于它们的较大尺寸、结构多样性和异常数量的翻译后修饰,也落在代谢组学或蛋白质组学方法的范围之外。 该提案概述了开发战略,以创建一套工具,通过基于质谱的基因组挖掘利用核糖体编码的天然产物的生物合成潜力。作为所提出的工作的结果而创建的技术和方法不仅对于检测治疗性先导化合物是重要的,而且对于有效表征由病原性细菌(例如金黄色葡萄球菌、蜡状芽孢杆菌和艰难梭菌)分泌的核糖体编码的毒素以及由高等真核生物(例如海洋蜗牛、灵长类动物和人类)产生的防御素也是重要的。 公共卫生相关性:这项工作概述了一种方法,实验地雷基因组序列的遗传编码分子控制生物学。这些分子是治疗开发的重要先导化合物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PIETER C DORRESTEIN其他文献

PIETER C DORRESTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PIETER C DORRESTEIN', 18)}}的其他基金

Reverse Metabolomics for the Discovery of Disease Associated Microbial Molecules
用于发现疾病相关微生物分子的反向代谢组学
  • 批准号:
    10651361
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
Collaborative Microbial Metabolite Center
微生物代谢物协作中心
  • 批准号:
    10512719
  • 财政年份:
    2022
  • 资助金额:
    $ 46.87万
  • 项目类别:
Cross Repository Metabolomics Data and Workflow Integration
跨存储库代谢组学数据和工作流程集成
  • 批准号:
    10576731
  • 财政年份:
    2022
  • 资助金额:
    $ 46.87万
  • 项目类别:
Mapping the Secondary Metabolomes of Marine Cyanobacteria
绘制海洋蓝细菌的次级代谢组图
  • 批准号:
    8562582
  • 财政年份:
    2013
  • 资助金额:
    $ 46.87万
  • 项目类别:
Mapping the Secondary Metabolomes of Marine Cyanobacteria
绘制海洋蓝细菌的次级代谢组图
  • 批准号:
    8729611
  • 财政年份:
    2013
  • 资助金额:
    $ 46.87万
  • 项目类别:
Mapping the Secondary Metabolomes of Marine Cyanobacteria
绘制海洋蓝细菌的次级代谢组图
  • 批准号:
    9167954
  • 财政年份:
    2013
  • 资助金额:
    $ 46.87万
  • 项目类别:
Mapping the Secondary Metabolomes of Marine Cyanobacteria
绘制海洋蓝细菌的次级代谢组图
  • 批准号:
    9066743
  • 财政年份:
    2013
  • 资助金额:
    $ 46.87万
  • 项目类别:
Experiment based genome mining of ribosomal natural products
基于实验的核糖体天然产物基因组挖掘
  • 批准号:
    8625312
  • 财政年份:
    2012
  • 资助金额:
    $ 46.87万
  • 项目类别:
Experiment based genome mining of ribosomal natural products
基于实验的核糖体天然产物基因组挖掘
  • 批准号:
    8448101
  • 财政年份:
    2012
  • 资助金额:
    $ 46.87万
  • 项目类别:
Experiment based genome mining of ribosomal natural products
基于实验的核糖体天然产物基因组挖掘
  • 批准号:
    8838182
  • 财政年份:
    2012
  • 资助金额:
    $ 46.87万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.87万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 46.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 46.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了